TRAF4 and neoplasm: To further test the combinatorial effects in vivo, the anti-tumor efficacy of TRAF4/5/6 targeted siRNAs, and retinoic acid was evaluated using the human SK-OV-3 and MeWo xenograft models established on nude mice.